Microba Life Sciences Limited

ASX:MAP.AX

0.18 (AUD) • At close September 6, 2024
Bedrijfsnaam Microba Life Sciences Limited
Symbool MAP.AX
Munteenheid AUD
Prijs 0.18
Beurswaarde 80,613,360
Dividendpercentage 0%
52-weken bereik 0.145 - 0.359
Industrie Diagnostics & Research
Sector Healthcare
CEO Dr. Luke Reid
Website https://microba.com

An error occurred while fetching data.

Over Microba Life Sciences Limited

Microba Life Sciences Limited provides microbiome testing and analysis services for clinicians, consumers, and research customers in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. It offers pathology, therapeutics, and diagnostics services based on the human gut microbiome; Databank, for discovery of therapeutic

Vergelijkbare Aandelen

Orthocell Limited logo

Orthocell Limited

OCC.AX

0.4 AUD

Antisense Therapeutics Limited logo

Antisense Therapeutics Limited

ANP.AX

0.058 AUD

Emyria Limited logo

Emyria Limited

EMD.AX

0.044 AUD

MedAdvisor Limited logo

MedAdvisor Limited

MDR.AX

0.345 AUD

Noxopharm Limited logo

Noxopharm Limited

NOX.AX

0.11 AUD

Biotron Limited logo

Biotron Limited

BIT.AX

0.017 AUD

Micro-X Limited logo

Micro-X Limited

MX1.AX

0.058 AUD

Invion Limited logo

Invion Limited

IVX.AX

0.002 AUD

Doctor Care Anywhere Group PLC logo

Doctor Care Anywhere Group PLC

DOC.AX

0.068 AUD

Financiële Gegevens

Cijfers zijn in miljoenen (AUD)

Cijfers zijn in miljoenen (AUD)